Therapeutic Plasma Exchange and Immunoadsorption: Indications and Implementation
- 28 November 2019
- book chapter
- Published by Springer Nature
- p. 135-150
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic SyndromeChest, 2017
- Therapeutic Plasma Exchange and Its Impact on Drug LevelsAmerican Journal of Clinical Pathology, 2017
- Plasmapheresis for the treatment of kidney diseasesKidney International, 2016
- High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 GlomerulopathiesJournal of the American Society of Nephrology, 2016
- Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitusAtherosclerosis Supplements, 2015
- Adult-Onset Eculizumab-Resistant Hemolytic Uremic Syndrome Associated With Cobalamin C DeficiencyAmerican Journal of Kidney Diseases, 2014
- Autoantibodies to coagulation factors: From pathophysiology to diagnosis and therapyAutoimmunity Reviews, 2014
- Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical PhenotypeJournal of the American Society of Nephrology, 2013
- Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the diseaseHuman Molecular Genetics, 2003
- Coagulation Abnormalities following Intensive Plasma Exchange on the Cell SeparatorBritish Journal of Haematology, 1981